Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merit Cudkowicz

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 1, 2022
Preventing Amyotrophic Lateral Sclerosis Before It Starts: When to Intervene?Merit Cudkowicz
Nature Clinical Practice. Neurology|August 26, 2006
Is pentoxifylline safe and effective in patients with amyotrophic lateral sclerosis?Scott Lindhorst, Merit Cudkowicz
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
North East ALS Study GroupMerit Cudkowicz, Jeremy Shefner
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|June 25, 2008
Therapy development for ALS: lessons learned and path forwardVeena Lanka, Merit Cudkowicz
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 30, 2014
Opportunities for improving therapy development in ALSLucie Bruijn, Merit Cudkowicz,
The Lancet. Neurology|April 23, 2011
Emerging targets and treatments in amyotrophic lateral sclerosisLorne Zinman, Merit Cudkowicz
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2008
ALS drug development: reflections from the past and a way forwardSwati Aggarwal, Merit Cudkowicz
Expert Review of Neurotherapeutics|March 15, 2006
Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapiesLucie I Bruijn, Merit Cudkowicz
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 15, 2008
Design of phase II ALS clinical trialsDavid A Schoenfeld, Merit Cudkowicz
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Measures and markers in amyotrophic lateral sclerosisMerit Cudkowicz, Muhammad Qureshi, Jeremy Shefner
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 1, 2022
Preventing Amyotrophic Lateral Sclerosis Before It Starts: When to Intervene?Merit Cudkowicz
Nature Clinical Practice. Neurology|August 26, 2006
Is pentoxifylline safe and effective in patients with amyotrophic lateral sclerosis?Scott Lindhorst, Merit Cudkowicz
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
North East ALS Study GroupMerit Cudkowicz, Jeremy Shefner
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|June 25, 2008
Therapy development for ALS: lessons learned and path forwardVeena Lanka, Merit Cudkowicz
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 30, 2014
Opportunities for improving therapy development in ALSLucie Bruijn, Merit Cudkowicz,
The Lancet. Neurology|April 23, 2011
Emerging targets and treatments in amyotrophic lateral sclerosisLorne Zinman, Merit Cudkowicz
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|November 21, 2008
ALS drug development: reflections from the past and a way forwardSwati Aggarwal, Merit Cudkowicz
Expert Review of Neurotherapeutics|March 15, 2006
Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapiesLucie I Bruijn, Merit Cudkowicz
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 15, 2008
Design of phase II ALS clinical trialsDavid A Schoenfeld, Merit Cudkowicz
Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Measures and markers in amyotrophic lateral sclerosisMerit Cudkowicz, Muhammad Qureshi, Jeremy Shefner
Pageof 12